Filing Details
- Accession Number:
- 0001593968-25-000043
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-06 21:13:34
- Reporting Period:
- 2025-01-02
- Accepted Time:
- 2025-01-06 21:13:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1824893 | Surrozen Inc. | SRZN | Biological Products, (No Disgnostic Substances) (2836) | 301374889 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1990537 | Yang Li | C/O Surrozen, Inc. 171 Oyster Point Blvd., Suite 400 South San Francisco CA 94080 | Exec. Vice President, Research | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-01-02 | 2,500 | $0.00 | 14,188 | No | 4 | M | Direct | |
Common Stock | Disposition | 2025-01-03 | 843 | $17.37 | 13,345 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Footnotes
- Each restricted stock unit, or RSU, represents a contingent right to receive one share of the Issuer's common stock. This transaction represents the settlement of vested RSUs in shares of Issuer's common stock.
- Includes 400 shares purchased at a price of $5.67 per share pursuant to the Issuer's 2021 Employee Stock Purchase Plan on December 13, 2024, and 702 shares held through immediate family members of the reporting person.
- The shares were sold to cover withholding taxes upon vesting of RSUs in transactions that were initiated by the Issuer on the reporting person's behalf. The price reported reflects the volume-weighted average price for the transactions.